-
Je něco špatně v tomto záznamu ?
Random mutagenesis of human serine racemase reveals residues important for the enzymatic activity
Hillary E. Hoffman, Jana Jirásková, Marketa Zvelebil and Jan Konvalinka
Jazyk angličtina Země Česko
NLK
ProQuest Central
od 2005-01-01 do 2011
- MeSH
- aktivace enzymů MeSH
- amyotrofická laterální skleróza diagnóza terapie MeSH
- genetická transkripce MeSH
- mutageneze MeSH
- proliferace buněk MeSH
- pyridoxalfosfát analogy a deriváty MeSH
- receptory N-methyl-D-aspartátu MeSH
- serin antagonisté a inhibitory MeSH
Human serine racemase (hSR) is a cytosolic pyridoxal-5'-phosphate dependent enzyme responsible for production of D-serine in the central nervous system. D-Serine acts as an endogenous coagonist of N-methyl-D-aspartate receptor ion channels. Increased levels of D-serine have been linked to amyotrophic lateral sclerosis and Alzheimer's disease, indicating that SR inhibitors might be useful tools for investigation or treatment of neurodegenerative diseases. However, despite hSR's promise as a therapeutic target, relatively few specific inhibitors have been identified, which is due in part to the lack of a three-dimensional structure of the enzyme. Here, we present a strategy for the generation and screening of random hSR mutants. From a library of randomly mutated hSR variants, twenty-seven soluble mutants were selected, expressed, and evaluated for enzymatic activity. Taking three carefully characterized mutants as an example, we show how this strategy can be used to pinpoint structurally and functionally important residues. In particular, we identify S84 and P111 as residues crucial for hSR activity and C217 and K221 as residues important for binding of the Mg2+ cofactor as well as for overall stability of the enzyme.
Lit.: 37
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11007729
- 003
- CZ-PrNML
- 005
- 20111210203552.0
- 008
- 110418s2010 xr e eng||
- 009
- eAR
- 024 7_
- $2 doi $a 10.1135/cccc2010003
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hoffman, Hillary. $7 _AN059391
- 245 10
- $a Random mutagenesis of human serine racemase reveals residues important for the enzymatic activity / $c Hillary E. Hoffman, Jana Jirásková, Marketa Zvelebil and Jan Konvalinka
- 314 __
- $a Department of Biochemistry, Faculty of Science, Charles University in Prague, Hlavova 8, 128 43 Prague 2, Czech Republic b Gilead Sciences and IOCB Research Center, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 504 __
- $a Lit.: 37
- 520 9_
- $a Human serine racemase (hSR) is a cytosolic pyridoxal-5'-phosphate dependent enzyme responsible for production of D-serine in the central nervous system. D-Serine acts as an endogenous coagonist of N-methyl-D-aspartate receptor ion channels. Increased levels of D-serine have been linked to amyotrophic lateral sclerosis and Alzheimer's disease, indicating that SR inhibitors might be useful tools for investigation or treatment of neurodegenerative diseases. However, despite hSR's promise as a therapeutic target, relatively few specific inhibitors have been identified, which is due in part to the lack of a three-dimensional structure of the enzyme. Here, we present a strategy for the generation and screening of random hSR mutants. From a library of randomly mutated hSR variants, twenty-seven soluble mutants were selected, expressed, and evaluated for enzymatic activity. Taking three carefully characterized mutants as an example, we show how this strategy can be used to pinpoint structurally and functionally important residues. In particular, we identify S84 and P111 as residues crucial for hSR activity and C217 and K221 as residues important for binding of the Mg2+ cofactor as well as for overall stability of the enzyme.
- 650 _2
- $a receptory N-methyl-D-aspartátu $7 D016194
- 650 _2
- $a pyridoxalfosfát $x analogy a deriváty $7 D011732
- 650 _2
- $a serin $x antagonisté a inhibitory $7 D012694
- 650 _2
- $a amyotrofická laterální skleróza $x diagnóza $x terapie $7 D000690
- 650 _2
- $a genetická transkripce $7 D014158
- 650 _2
- $a mutageneze $7 D016296
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a proliferace buněk $7 D049109
- 700 1_
- $a Jirásková, Jana $7 xx0102285
- 700 1_
- $a Zvelebil, Marketa J. $7 osa2009541960
- 700 1_
- $a Konvalinka, Jan, $d 1963- $7 mzk2004208597
- 773 0_
- $w MED00010973 $t Collection of Czechoslovak chemical communications $g Roč. 75, č. 1 (2010), s. 59-79 $x 0010-0765
- 910 __
- $a ABA008 $b online $c 394 $y 7
- 990 __
- $a 20110418120729 $b ABA008
- 991 __
- $a 20110419090918 $b ABA008
- 999 __
- $a ok $b bmc $g 835474 $s 699895
- BAS __
- $a 3 $a 4
- BMC __
- $a 2010 $b 75 $c 1 $d 59-79 $m Collection of Czechoslovak Chemical Communications $x MED00010973
- LZP __
- $a 2011-23/vtjs